ADD kunye ne-SAD unyango kunye neMpawu

Unyango, iMpawu kunye Nezizathu

Ingxaki-ukusilahla / ukungasebenzi kakuhle (ADD okanye i-ADHD) imeko yambi ngezinye iimeko ezinxulumene nengxaki yokuxhalaxwa kwentlalo (SAD) . Abantu abane-ADD babandezeleka okanye bangakhathalelekanga kunye nokuphazamiseka, ukunyanzeliswa nokunyanzeliswa, okanye zombini. I-ADD iyona nto ixhaphakileyo yengqondo kubantwana kunye neempawu zihlala ziba ngabantu abadala. Ngaphandle kokonyango olufanelekileyo, i-ADD ingabangela ukuzithemba okuphantsi , ubudlelwane obubi kunye neengxaki emsebenzini okanye kwisikolo.

Ubudlelwane phakathi koxinzelelo lweNtlalo kunye nokukhathazeka-ukulahleka / ukugula ngengxaki

Iziphumo ze-National Comorbidity Survey Replication (NCSR) zibonisa ukuba malunga nesiqingatha sabadala abane-ADD banokukhathazeka ngenxa yengxaki yokuxhalabisa. Uphando luye lwabonisa ukuba i-SAD ibe enye yeengxaki ezixhaphakileyo ezixhaphakileyo kubantu abane-ADD. Ukongezelela, abantu abahluphekayo kwi-ADD kunye neengxaki zokuxhalaba kwentlalo baye baboniswa ukuphuhlisa i-SAD ngaphambili kwaye banamava anzima ngakumbi kunabo abanenkinga yokuxhalaba kwintlalo yodwa. Ukuba le miqathango idibeneyo inokuyingozi kakhulu ukusebenza.

Unyango lwe-Co-Occurring SAD ne-ADD

Unyango lwentsebenziswano ye-SAD kunye ne-ADD ehambelana nxamnye nenyaniso yokuba abo abaneengxaki zokuxhalabisa abantu baphendule ngokuthe ngqo kumachiza avuselelayo asetyenziswayo ekuphatheni i-ADD, njengoRitalin. Kukho ubungqina bokuba imithi engeyiyo ivuselela njengeStrattera (i-atomoxetine) isebenza ngokuphumelelayo ekuphatheni i-ADD kulabo abane-disorder disorder disorder disorder.

Ukuba unyango luyinxalenye yonyango lwakho, ugqirha wakho uya kusebenza nawe ukufumanisa ukhetho olungcono kwiimeko zakho.

Ulwaphulo lwe-ADD luquka iindlela ezisetyenziselwa i-SAD ezifana nokunyanga kokuziphatha kunye noqeqesho lwezentlalo . I-ctnitive-behavioral therapy (CBT) iboniswe ukuba luncedo kakhulu ekulawuleni iimpawu ze-ADD kunye neengxaki zokuxhalabisa abantu.

Nangona iindlela ezifanayo zingasetyenziselwa, ugxininiso lweyeza luyahlukahluka kuxhomekeke ekubeni ingaba i-ADD okanye impawu ze-SAD zijoliswe. Ukuba ufumene i-ADD kunye neengxaki zokuxhalaba kwentlalo, ugqirha wakho uya kugqiba inkcazo yeyona ndlela efanelekileyo yokujongana neempawu zesifo ngasinye. Ugqirha wakho uya kugqiba ukuba ngubani, ukuba ngaba, kukubangela ukuba uxinzelelo olubaluleke kakhulu xa ugqiba ukuba ngubani oza kunyanga kuqala.

Iimpawu ze-ADHD yabantu abadala

EUnited States, malunga nama-60% abantwana abane-ADHD bakhula ukuba babe ngabantu abadala abane-ADHD. Kukho abantu abayizigidi ezisibhozo zabantu abadala, okanye i-4% yabemi. Nangona kunjalo, nangona kunjalo, malunga nama-20% kuphela abo bantu abadala baye bafumaniswa kwaye / okanye baphathwa kunye nekota kuphela bafumana uncedo kwi-ADHD yabo.

Enye into ebalulekileyo kunye ne-ADHD yabantu abadala kukuba ubunzima bakho kufuneka babuyele ebuntwaneni bakho kwaye kufuneka baphazamise ubuninzi benkalo ebomini bakho, njengomsebenzi kunye nobudlelwane. Ukuba usanda kuqalisa ukufumana ubunzima, ugqirha wakho uza kujonga ezinye izizathu.

Iimpawu ze-ADHD kubantu abadala ziquka:

Izizathu ze-ADHD

Njengengxaki ezininzi, akukho mntu uyazi kakuhle oko kubangela i-ADHD. Nangona kunjalo, kukho iimeko ezinokuchaphazela uphuhliso, kuquka:

Imithombo:

Adler LA, uLiebowitz M, uKroneneberger W, et al. I-Atomoxetine unyango kubantu abadala abanokukhathazeka ngengxaki yokuxhatshazwa kwempilo kunye nokukhathazeka kokukhathazeka kweentlalo. Ukuxinezeleka nokuxhalabisa . 2009; 26 (3): 212-221.

UJohnston, C. Abantwana abanenkinga yokukhathazeka kunye nokukhathazeka kweentlalo kubonisa ukulahleka okukhulu kwalabo abane-ADHD yodwa: I-ADAA. Ufikelele ngoJulayi 6, 2010.

Surman, CBH. Ukunyanzeliswa komntu omdala kwi-ADHD. Ufikelele ngoJulayi 6, 2010.

"ADDD yabantu abadala (i-Attention-Deficit / Hyperactive Disorder)." Ukuxhalabisa kunye nokuPhukisa uMbutho waseMelika (2016).

"Ukukhathazeka kwabantu abadala / i-disorder disorder (ADHD)." I-Clinical Mayo (2016).